Science Needs a Solution for the Temptation of Positive Results - The New York Times

"A few years back, scientists at the biotechnology company Amgen set out to replicate 53 landmark studies that argued for new approaches to treat cancers using both existing and new molecules. They were able to replicate the findings of the original research only 11 percent of the time.

Science has a reproducibility problem. And the ramifications are widespread."